Pharma Cyte Biotech Inc - Understand $pmcb stock

$PMCB Market Cap: $14.88 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

$23.05M

TTM

Current Assets

$32.88M

Q3 2024

Current Liabilities

$7.473M

Q3 2024

Current Ratio

439.92%

Q3 2024

Total Assets

$70.19M

Q3 2024

Total Liabilities

$17.15M

Q3 2024

Book Value

$53.04M

Q3 2024

Cash

$32.64M

Q3 2024

P/E

0.6455

Sep 18, 2024 EST

Free Cash Flow

Revenues

Revenue YoY Change

Revenues

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$12.16K	$66.56K	$130.0K	$260.0K	$650.0K	$1.190M	$1.170M	$540.0K	$90.00K	$0.00	$0.00	$0.00
YoY Change											-100.0%	-81.73%	-48.8%	-50.0%	-60.0%	-45.38%	1.71%	116.67%	500.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$12.16K	$66.56K	$130.0K	$260.0K	$650.0K	$1.190M	$1.170M	$540.0K	$90.00K	$0.00	$0.00	$0.00
Cost Of Revenue									$0.00	$0.00	$0.00	$9.620K	$19.38K	$30.00K	$230.0K	$430.0K	$270.0K	$170.0K	$0.00	$40.00K	$0.00	$0.00
Gross Profit									$0.00	$0.00	$0.00	$2.540K	$47.18K	$90.00K	$30.00K	$230.0K	$920.0K	$1.000M	$540.0K	$50.00K	$0.00	$0.00
Gross Profit Margin												20.89%	70.88%	69.23%	11.54%	35.38%	77.31%	85.47%	100.0%	55.56%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Selling, General & Admin	$6.113M	$5.987M	$3.701M	$2.707M	$3.525M	$3.641M	$4.984M	$3.260M	$4.666M	$9.784M	$18.98M	$723.7K	$427.3K	$470.0K	$1.710M	$5.790M	$4.260M	$4.070M	$7.430M	$3.100M	$310.0K	$30.00K	$30.00K
YoY Change	2.1%	61.76%	36.74%	-23.22%	-3.17%	-26.95%	52.88%	-30.14%	-52.31%	-48.45%	2522.69%	69.35%	-9.08%	-72.51%	-70.47%	35.92%	4.67%	-45.22%	139.68%	900.0%	933.33%	0.0%
% of Gross Profit												28491.5%	905.82%	522.22%	5700.0%	2517.39%	463.04%	407.0%	1375.93%	6200.0%
Research & Development	$407.4K	$468.5K	$690.9K	$916.2K	$301.2K	$460.1K	$1.998M	$1.182M	$1.407M	$3.477M	$320.0K			$10.00K	$490.0K	$470.0K	$410.0K	$130.0K	$120.0K	$1.110M	$1.410M	$0.00
YoY Change	-13.04%	-32.19%	-24.59%	204.18%	-34.52%	-76.97%	68.98%	-15.97%	-59.53%	986.53%				-97.96%	4.26%	14.63%	215.38%	8.33%	-89.19%	-21.28%
% of Gross Profit														11.11%	1633.33%	204.35%	44.57%	13.0%	22.22%	2220.0%
Depreciation & Amortization												$0.00	$24.66K	$40.00K	$110.0K	$30.00K	$10.00K	$0.00	$0.00	$20.00K	$0.00
YoY Change												-100.0%	-38.35%	-63.64%	266.67%	200.0%			-100.0%
% of Gross Profit												0.0%	52.27%	44.44%	366.67%	13.04%	1.09%	0.0%	0.0%	40.0%
Operating Expenses	$8.520M	$6.455M	$4.392M	$3.623M	$3.826M	$4.101M	$6.981M	$4.442M	$6.073M	$13.26M	$18.98M	$1.687M	$1.996M	$480.0K	$2.190M	$6.270M	$4.670M	$4.210M	$7.550M	$4.210M	$1.720M	$30.00K	$30.00K
YoY Change	31.98%	46.98%	21.23%	-5.32%	-6.69%	-41.26%	57.16%	-26.86%	-54.2%	-30.13%	1025.14%	-15.5%	315.91%	-78.08%	-65.07%	34.26%	10.93%	-44.24%	79.33%	144.77%	5633.33%	0.0%
Operating Profit	-$8.520M	-$6.455M	-$4.392M	-$3.623M					-$6.073M	-$13.26M	-$18.98M	-$1.684M	-$1.949M	-$390.0K	-$2.160M	-$6.040M	-$3.750M	-$3.210M	-$7.010M	-$4.160M	-$1.720M	-$30.00K
YoY Change	31.98%	46.98%	21.23%						-54.2%	-30.13%	1026.84%	-13.59%	399.79%	-81.94%	-64.24%	61.07%	16.82%	-54.21%	68.51%	141.86%	5633.33%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Interest Expense	$4.488M	$1.938M	$509.00	$3.046K	-$450.00		$0.00	-$1.540K	-$1.190K	-$4.940K	-$20.00K	$112.7K	$230.1K	-$170.0K	-$290.0K	$0.00	-$40.00K	-$10.00K	-$60.00K	-$120.0K	$0.00	$0.00
YoY Change	131.63%	380548.33%	-83.29%	-776.89%			-100.0%	29.41%	-75.91%	-75.3%	-117.75%	-51.03%	-235.34%	-41.38%		-100.0%	300.0%	-83.33%	-50.0%
% of Operating Profit
Other Income/Expense, Net	$8.854M	$202.0K	$152.9K	$71.75K	-$40.00	$33.40K	$152.6K	$0.00	$10.54K	$0.00	$0.00	$86.26K	$49.87K	-$730.0K	-$30.00K	$0.00
YoY Change	4283.05%	32.15%	113.05%	-179462.5%	-100.12%	-78.11%		-100.0%			-100.0%	72.97%	-106.83%	2333.33%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Pretax Income	$333.8K	-$4.316M	-$4.239M	-$3.551M	-$3.827M	-$4.067M	-$6.829M	-$4.444M	-$6.064M	-$9.928M	-$27.25M	-$1.600M	-$1.900M	-$1.400M	-$5.990M	-$6.040M	-$3.790M	-$3.620M	-$9.100M	-$4.280M	-$1.730M	-$30.00K	-$30.00K
YoY Change	-107.73%	1.81%	19.37%	-7.2%	-5.91%	-40.44%	53.67%	-26.72%	-38.92%	-63.57%	1603.13%	-15.79%	35.71%	-76.63%	-0.83%	59.37%	4.7%	-60.22%	112.62%	147.4%	5666.67%	0.0%
Income Tax	$0.00	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%
Net Earnings	$333.8K	-$4.316M	-$4.239M	-$3.551M	-$3.827M	-$4.067M	-$6.829M	-$4.444M	-$6.064M	-$9.928M	-$27.25M	-$1.598M	-$1.899M	-$1.400M	-$5.990M	-$6.040M	-$3.790M	-$3.620M	-$9.390M	-$4.280M	-$1.730M	-$30.00K	-$30.00K
YoY Change	-107.73%	1.81%	19.37%	-7.2%	-5.91%	-40.44%	53.67%	-26.72%	-38.92%	-63.57%	1605.15%	-15.86%	35.67%	-76.63%	-0.83%	59.37%	4.7%	-61.45%	119.39%	147.4%	5666.67%	0.0%
Net Earnings / Revenue												-13142.29%	-2853.62%	-1076.92%	-2303.85%	-929.23%	-318.49%	-309.4%	-1738.89%	-4755.56%
Basic Earnings Per Share	-$1.80	-$0.22	-$0.27	-$2.45								$0.00	-$0.01
Diluted Earnings Per Share	-$1.80	-$0.22	-$0.27	-$2.45	-$4.213M	-$5.518M	-$10.52M	-$7.846M	-$12.03M	-$14.10K	-$46.72K	-$3.629K	-$5.070K	-$3.996K	-$17.05K	-$29.96K	-$22.57K	-$22.29K	-$68.71K	-$41.21K	-$19.28K	-$340.90	-$340.90

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Cash & Short-Term Investments	$50.18M	$68.04M	$85.40M	$2.202M	$894.9K	$515.3K	$1.060M	$3.464M	$1.921M	$2.700M	$3.620M	$200.0K	$20.00K	$60.00K	$0.00	$640.0K	$1.510M	$1.110M	$1.070M	$240.0K	$80.00K	$0.00
YoY Change	-26.25%	-20.33%	3778.13%	146.08%	73.67%	-51.38%	-69.41%	80.35%	-28.85%	-25.42%	1710.0%	900.0%	-66.67%		-100.0%	-57.62%	36.04%	3.74%	345.83%	200.0%
Cash & Equivalents
Short-Term Investments															$0.00	$30.00K	$0.00		$0.00	$200.0K	$0.00
Other Short-Term Assets	$259.8K	$107.7K	$94.17K	$73.13K	$142.8K	$138.2K	$224.1K	$74.27K	$110.0K	$1.468M	$570.0K	$1.650M	$1.030M	$30.00K	$0.00	$210.0K	$1.490M	$2.090M	$2.060M	$10.00K	$0.00
YoY Change	141.27%	14.35%	28.77%	-48.78%	3.36%	-38.35%	201.7%	-32.5%	-92.51%	157.59%	-65.45%	60.19%	3333.33%		-100.0%	-85.91%	-28.71%	1.46%	20500.0%
Inventory												$0.00	$10.00K	$20.00K	$0.00	$120.0K	$240.0K	$0.00		$0.00	$50.00K	$0.00
Prepaid Expenses
Receivables												$0.00	$0.00	$0.00	$10.00K	$160.0K	$380.0K	$230.0K	$0.00	$0.00	$0.00
Other Receivables												$0.00	$0.00	$0.00	$0.00	$60.00K	$110.0K	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$50.44M	$68.15M	$85.49M	$2.275M	$1.038M	$653.4K	$1.284M	$3.539M	$2.031M	$4.168M	$4.190M	$1.850M	$1.060M	$100.0K	$10.00K	$1.180M	$3.740M	$3.430M	$3.130M	$240.0K	$130.0K	$0.00
YoY Change	-25.98%	-20.29%	3657.62%	119.27%	58.81%	-49.11%	-63.72%	74.24%	-51.28%	-0.52%	126.49%	74.53%	960.0%	900.0%	-99.15%	-68.45%	9.04%	9.58%	1204.17%	84.62%
Property, Plant & Equipment												$0.00	$0.00	$50.00K	$110.0K	$2.640M	$20.00K	$10.00K	$10.00K	$90.00K	$50.00K	$0.00
YoY Change													-100.0%	-54.55%	-95.83%	13100.0%	100.0%	0.0%	-88.89%	80.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$1.572M	$1.572M	$1.572M	$1.572M	$1.572M	$1.572M	$1.572M	$1.572M	$1.572M	$1.570M	$0.00
YoY Change	-100.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.14%
Other Assets	$5.160M	$7.690K	$7.690K	$7.370K	$7.370K	$7.370K	$7.370K	$7.370K	$7.850K	$7.850K	$10.00K	$1.030M	$1.030M	$1.080M	$1.080M	$0.00	$2.990M	$0.00	$2.000M	$120.0K
YoY Change	66996.1%	0.0%	4.34%	0.0%	0.0%	0.0%	0.0%	-6.11%	0.0%	-21.5%	-99.03%	0.0%	-4.63%	0.0%		-100.0%		-100.0%	1566.67%
Total Long-Term Assets	$9.464M	$5.129M	$5.129M	$5.129M	$5.129M	$5.129M	$5.129M	$5.129M	$5.129M	$5.129M	$5.130M	$1.030M	$1.030M	$1.140M	$1.190M	$5.660M	$3.880M	$980.0K	$2.010M	$100.0K	$50.00K	$0.00
YoY Change	84.51%	0.0%	0.01%	0.0%	0.0%	0.0%	0.0%	-0.01%	0.0%	-0.01%	398.06%	0.0%	-9.65%	-4.2%	-78.98%	45.88%	295.92%	-51.24%	1910.0%	100.0%
Total Assets	$59.90M	$73.28M	$90.62M	$7.404M	$6.167M	$5.782M	$6.413M	$8.668M	$7.160M	$9.297M	$9.320M	$2.880M	$2.090M	$1.240M	$1.200M	$6.840M	$7.620M	$4.410M	$5.140M	$340.0K	$180.0K	$0.00
YoY Change
Accounts Payable	$389.4K	$128.3K	$205.4K	$172.3K	$185.8K	$121.9K	$352.6K	$365.6K	$336.0K	$496.7K	$190.0K	$770.0K	$1.090M	$710.0K	$670.0K	$210.0K	$140.0K	$100.0K	$80.00K	$260.0K	$0.00	$0.00	$10.00K
YoY Change	203.53%	-37.53%	19.22%	-7.31%	52.47%	-65.43%	-3.55%	8.81%	-32.35%	161.42%	-75.32%	-29.36%	53.52%	5.97%	219.05%	50.0%	40.0%	25.0%	-69.23%			-100.0%
Accrued Expenses	$735.2K	$458.3K	$499.0K	$552.5K	$816.6K	$621.0K	$291.6K	$214.7K	$151.6K	$23.67K	$40.00K	$60.00K	$420.0K	$270.0K	$100.0K	$220.0K	$30.00K	$20.00K	$0.00	$40.00K	$0.00
YoY Change	60.42%	-8.16%	-9.68%	-32.34%	31.51%	112.99%	35.83%	41.56%	540.6%	-40.83%	-33.33%	-85.71%	55.56%	170.0%	-54.55%	633.33%	50.0%		-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due				$0.00	$28.92K						$0.00	$420.0K	$2.090M	$2.370M	$2.280M	$490.0K	$0.00
YoY Change				-100.0%							-100.0%	-79.9%	-11.81%	3.95%	365.31%
Total Short-Term Liabilities	$7.421M	$586.6K	$704.4K	$724.8K	$1.031M	$742.9K	$644.2K	$580.3K	$637.6K	$1.520M	$370.0K	$3.800M	$3.790M	$3.390M	$3.050M	$920.0K	$180.0K	$120.0K	$110.0K	$300.0K	$0.00	$0.00	$10.00K
YoY Change	1165.17%	-16.72%	-2.82%	-29.73%	38.84%	15.32%	11.02%	-9.0%	-58.06%	310.91%	-90.26%	0.26%	11.8%	11.15%	231.52%	411.11%	50.0%	9.09%	-63.33%			-100.0%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$46.28K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$1.930M	$0.00	$0.00	$510.0K	$1.280M	$330.0K	$0.00	$0.00
YoY Change				-100.0%										-100.0%	-94.82%			-100.0%	-60.16%	287.88%
Other Long-Term Liabilities	$12.97M																	$0.00	$110.0K	$60.00K	$0.00	$0.00
YoY Change																		-100.0%	83.33%
Total Long-Term Liabilities	$12.97M	$0.00	$0.00	$0.00	$46.28K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$100.0K	$1.930M	$0.00	$0.00	$620.0K	$1.340M	$330.0K	$0.00	$0.00
YoY Change				-100.0%										-100.0%	-94.82%			-100.0%	-53.73%	306.06%
Total Liabilities	$20.39M	$586.6K	$704.4K	$724.8K	$1.078M	$742.9K	$644.2K	$580.3K	$637.6K	$1.520M	$370.0K	$3.800M	$3.790M	$3.390M	$3.150M	$2.850M	$180.0K	$120.0K	$720.0K	$1.630M	$330.0K	$0.00	$10.00K
YoY Change	3375.96%	-16.72%	-2.82%	-32.75%	45.07%	15.32%	11.02%	-9.0%	-58.06%	310.91%	-90.26%	0.26%	11.8%	7.62%	10.53%	1483.33%	50.0%	-83.33%	-55.83%	393.94%		-100.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2024	2023	2022	2021	2013	2012
Basic Shares Outstanding	9.581M shares	19.49M shares	15.52M shares	1.448M shares	441.0M shares	374.8M shares
Diluted Shares Outstanding	9.581M shares	19.49M shares	15.52M shares	1.448M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $14.879 Million

About PharmaCyte Biotech Inc

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. The company is headquartered in Las Vegas, Nevada and currently employs 2 full-time employees. The company went IPO on 2003-09-11. The company is focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its product candidate is referred to as CypCaps. The Cell-in-a-Box encapsulation technology potentially enables genetically engineered live human cells to be used to produce various biologically active molecules. The company is advancing clinical research and development of new cellular-based therapies in oncology and diabetes. The company is also focused on developing therapies for pancreatic and other solid cancerous tumors by using genetically engineered live human cells. Its product candidate for the treatment of diabetes consists of encapsulated genetically modified insulin-producing cells. The company is also focused on the benefits of the Cell-in-a-Box technology to develop therapies for cancer that involve prodrugs based upon certain constituents of the Cannabis plant.

Industry: Biological Products, (No Diagnostic Substances) Peers: AquaBounty Technologies Inc Exagen Inc TYME TECHNOLOGIES, INC. Immunome Inc MEI Pharma Inc MERRIMACK PHARMACEUTICALS INC Sensei Biotherapeutics Inc Sera Prognostics Inc TScan Therapeutics Inc